No Detail Found!

Periplocin has anti-tumor actions in prostate cancer through modulating the miR-3614-5p/SLC4A4 axis

Author(s)
Jinjun Tian Department of Urology, Shanghai Pudong New Area People's Hospital,Chuanhuan South Road, Pudong New Area, Shanghai,China
Dingguo Zhang Department of Urology, Shanghai Pudong New Area People's Hospital,Chuanhuan South Road, Pudong New Area, Shanghai,China
Abstract
Periplocin (PPLN) can inhibit malignant tumors including prostate cancer (PC), but its impact on prostate cancer is unknown. Prostate cancer cells were treated with various doses of periplocin (PPLN), and the optimal treatment concentration of PPLN was determined using a CCK-8 assay. Bioinformatics analysis was performed to examine the link between miR-3614-5p and SLC4A4. The influences of miR-3614-5p and SLC4A4 levels on prostate cancer cells were analyzed using CCK-8, EdU, cell-scratch, Transwell, and flow cytometry analyses. A nude-mouse tumor model was created by injecting mice with PC3 cells subcutaneously. MiR-3614-5p and SLC4A4 levels in cancer cells and tumor tissues were measured using quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and western blot analyses. 100 nM PPLN dramatically decreased the proliferation, migration, and invasion of prostate cancer cells and promoted apoptosis. MiR-3614-5p reduced SLC4A4 levels, and both the reduction of miR-3614-5p and increase of SLC4A4 expression greatly promoted the malignancy behavior of cells. Low miR-3614-5p expression decreased PPLN's inhibitory effect on malignant behavior, which was reversed by down-regulation of SLC4A4. PPLN reduced tumor growth in mice, increased miR-3614-5p levels, and decreased SLC4A4 levels. In conclusion, PPLN exerted anti-prostate-cancer effects by modulating the miR-3614-5p/SLC4A4 axis.
Publication Details
Page(s) 1309-1320
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Prostate cancer, SLC4A4, malignant biological behavior, periplocin, miR-3614-5p
References
Bae ES,Byun WS,Ock CW,Kim WK,Park HJ,Lee SK .2023 .Periplocin exerts antitumor activity by regulating nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Biomed Pharmacother, 157 : 114039.
Bloise E,Braca A,De Tommasi N and Belisario MA .2009 .Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol., 64 : 793-802.
Cappellesso F,Orban MP,Shirgaonkar N,Berardi E,Serneels J,Neveu MA,Di Molfetta D,Piccapane F,Caroppo R,Debellis L,Ostyn T,Joudiou N,Mignion L,Richiardone E,Jordan BF,Gallez B,Corbet C,Roskams T,Dasgupta R,Tejpar S,Di Matteo M,Taverna D,Reshkin SJ,Topal B,Virga F,Mazzone M .2022 .Targeting the bicarbonate transporter slc4a4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nat Cancer, 3 : 1464-1483.
Feng Z,Ye Z,Xie J,Chen W,Li W,Xing C .2021 .Study on the mechanism of loxl1-as1/mir-3614-5p/yy1 signal axis in the malignant phenotype regulation of hepatocellular carcinoma. Biol Direct, 16 : 24.
Fu XP,Ji CY,Tang WQ,Yu TT,Luo L TT,Non-Coding Rna TT .2024 .-As1: A potential biomarker and therapeutic target in human malignant tumors. Clin. Exp. Med, 24 : 93.
Gandaglia G,Karakiewicz PI,Briganti A,Passoni NM,Schiffmann J,Trudeau V,Graefen M,Montorsi F,Sun M .2015 .Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur. Urol., 68 : 325-34.
Guccini I,Revandkar A,D'ambrosio M,Colucci M,Pasquini E,Mosole S,Troiani M,Brina D,SheibaniTezerji R,Elia AR,Rinaldi A,Pernigoni N,Ruschoff J H,Dettwiler S,De Marzo AM,Antonarakis ES,Borrelli C,Moor AE,Garcia-Escudero R,Alajati A,Attanasio G,Losa M,Moch H,Wild P,Egger G,Alimonti A .2021 .Senescence reprogramming by timp1 deficiency promotes prostate cancer metastasis. Cancer Cell, 39 : 68-82.
Guo S,Ma B,Jiang X,Li X,Jia Y .2020 .Astragalus polysaccharides inhibits tumorigenesis and lipid metabolism through mir-138-5p/sirt1/srebp1 pathway in prostate cancer. Front Pharmacol, 11 : 598.
Han L,Sun Y,Lu C,Ma C,Shi J,Sun D J .2021 .Mir3614-5p is a potential novel biomarker for colorectal cancer. Front Genet, 12 : 666833.
Hao J,Chang L,Wang D,Ji C,Zhang S,Hou Y,Wu Y Y .2023 .Periplocin alleviates cardiac remodeling in doca-salt-induced heart failure rats. J Cardiovasc Transl Res., 16 : 127-140.
Hsieh YH,Yu FJ,Nassef Y,Liu CJ,Chen YS,Lin CY,Feng JL,Wu MH .2022 .Targeting of mcl-1 expression by mirna-3614-5p promotes cell apoptosis of human prostate cancer cells. Int. J. Mol. Sci, 23 : 4194.
Hussen BM,Hidayat HJ,Salihi A,Sabir DK,Taheri M,Ghafouri-Fard S .2021 .Microrna: A signature for cancer progression. Biomed Pharmacother, 138 : 111528.
Khanmi K,Ignacimuthu S,Paulraj MG .2015 .. Clin Chim Acta, 451 : 154-60.
Lacouture A,Lafront C,Peillex C,Pelletier M and AudetWalsh E C .2022 .Impacts of endocrine-disrupting chemicals on prostate function and cancer. Environ Res., 204 : 112085.
Li F,Yang H,Kong T,Chen S,Li P,Chen L,Cheng J,Cui G,Zhang G .2020 .Pgam1, regulated by mir-3614- 5p, functions as an oncogene by activating transforming growth factor-beta (tgf-beta) signaling in the progression of non-small cell lung carcinoma. Cell Death Dis., 11 : 710.
Li Y,Li J,Zhou K,He J,Cao J,An M,Chang YX M .2016 .A review on phytochemistry and pharmacology of cortex periplocae. Molecules, 21 : 1702.
Lin JP,Huang MH,Sun ZT,Chen L,Lei YH,Huang Y Q,Qi M,Fan SR,Chung SG,Chan CW,Liu MC,Hu JS,Chen M,Ye MF,Chen WC,Deng YY,LJ YY .2023 .Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of mdscs through akt/nf-kappab pathway. Life Sci, 324 : 121715.
Liu J,Dong L,Zhu Y,Dong B,Sha J,Zhu HH,Pan J,Xue W (2022a). Prostate Cancer Treatment - China's Perspective J . .. Cancer Lett., 550 : 215927.
Lotan TL,Tomlins SA,Bismar TA,Van Der Kwast TH,Grignon D,Egevad L,Kristiansen G,Pritchard CC,Rubin MA,Bubendorf L MA .2020 .Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. I. molecular biomarkers in prostate cancer. Am. J. Surg Pathol, 44 : E15-E29.
Luo H,Vong CT,Chen H,Gao Y,Lyu P,Qiu L,Zhao M,Liu Q,Cheng Z,Zou J,Yao P,Gao C,Wei J,Ung CO L,Wang S,Zhong Z,Wang Y .2019 .Naturally occurring anti-cancer compounds: Shining from chinese herbal medicine. Chin Med, 14 : 48.
Markowski MC,Carducci MA .2017 .Early use of chemotherapy in metastatic prostate cancer. Cancer Treat Rev., 55 : 218-224.
Shang J,Wang Z,Chen W,Yang Z,Zheng L,Wang S,Li S S .2019 .Pseudogene chiap2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the wnt pathway. J Cell Physiol, 234 : 13735-13746.
Sharma K. K.,Gupta S.,Bisen P. S. .2025 .Enhancing Gastrointеstinal (GI) Cancer therapies with ganoderma lucidum: A review of mechanisms and efficacy. J Can Biomol Therap, 2 : 15-44.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A .2020 .Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Global cancer statistics, 71 : 209-249.
Wang G,Zhao D,Spring DJ,Depinho RA .2018 .Genetics and biology of prostate cancer. Genes Dev, 32 : 1105-1140.
Wang K,Fu S,Dong L,Zhang D,Wang M,Wu X,Shen E,Luo L,Li C,Nice EC,Huang C,Zou B C .2023 .Periplocin suppresses the growth of colorectal cancer cells by triggering Lgals3 (Galectin 3)-Mediated Lysophagy. , 19 : 3132-3150.
Wang Z,Tong D,Han C,Zhao Z,Wang X,Jiang T,Li Q,Liu S,Chen L,Chen Y,Li A,Huang C .2019 .Blockade of Mir-3614 maturation by Igf2bp3 Increases Trim25 expression and promotes breast cancer cell proliferation. , 41 : 357-369.
Xia C,Dong X,Li H,Cao M,Sun D,He S,Yang F,Yan X,Zhang S,Li N,Chen W .2022 .. Chin Med J (Engl), 135 : 584-590.
Xie G,Sun L,Li Y,Chen B,Wang C .2021 .Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via Ampk-Mtor signaling. Cancer Med, 10 : 325-336.
Xu W,Ding J,Li B,Sun T,You X,He Q,Sheng W .2023 .Effects of icariin and curcumol on autophagy, ferroptosis and lipid metabolism based on mir-7/mtor/srebp1 pathway on prostate cancer. Biofactors., 49 : 438-456.
Yao H,Zhou X,Zhou A,Chen J,Chen G,Shi X,Shi B,Tai Q,Mi X,Zhou G,Wang S,Sun J,Yang X,Yang Y,Cao H,Zhou D,Sun L.,Yao Y,He S Y .2023 .Functions as an oncogene in the progression of colorectal cancer. Mol. Carcinog, 62 : 771-785.
Yu C,Li H,Zhang C,Tang Y,Huang Y,Lu H,Jin K,Zhou J,Yang J .2024 .Solute carrier family 4 member 4 (slc4a4) is associated with cell proliferation, migration and immune cell infiltration in colon cancer. Discov Oncol., 15 : 597.
Yue Y,Tan M,Luo Y,Deng P,Wang H,Li J,Hao R,Tian L,Xie J,Chen M,Yu Z,Zhou Z,Pi H Z .2022 .Mir3614-5p downregulation promotes cadmium-induced breast cancer cell proliferation and metastasis by targeting txnrd1. Ecotoxicol Environ Saf, 247 : 114270.
Zhang X,Qiu H,Li C,Cai P,Qi F P .2021 .The positive role of traditional chinese medicine as an adjunctive therapy for cancer. Biosci Trends, 15 : 283-298.
Zhou J,Jiang YY,Chen H,Wu YC,Zhang L YC .2020 .Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of pi3k/akt/mtor pathway. Cell Prolif, 53 : E12739.
0

Citations

0

Downloads

169

Views